Company / Operating Income per Share
Immunome Inc. Operating Income per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.48
FY2025
5-year range
-$3.48 / -$2.18
FY2021-FY2025
Trend
-37.3%
vs FY2024
Sector context
#149 of 201
Health Care
What the data says
At $-3.48, Immunome Inc.'s operating income per share ranks #149 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 7 years, ranging from $-9.46 in FY2019 to $-2.18 in FY2021.
Based on SEC 10-K filings.
-3.48 in FY2025.
Declined from $-3.04 to $-3.48 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#149 of 201 in Health CareTop 74% of 201This company -$3.48 Sector average -$3.23
▼
-7.5% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 37.3% year-over-year.
- Ranks #149 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.48 | -37.3% |
| FY2024 | -$2.53 | +16.8% |
| FY2023 | -$3.04 | +0.0% |
| FY2022 | -$3.04 | -39.3% |
| FY2021 | -$2.18 | +39.6% |
| FY2020 | -$3.62 | +61.8% |
| FY2019 | -$9.46 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026